Browse articles from EyeWorld.org related to ASCRS. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
The ASOA Annual Meeting in conjunction with the ASCRS Annual Meeting will host 1 day of Pre-Conference Deep Dives followed by 4 days of its main program, which includes general sessions, roundtables, and practice management courses.
Recaps of a few recent papers from the Journal of Cataract & Refractive Surgery
EyeWorld Cornea Editor Clara Chan, MD, discusses “one of her most dramatic cases” involving ocular complications associated with rosacea, previews the content in the Cornea section of this issue, and shares excitement for the ASCRS Annual Meeting.
➤ FDA accepts NDA for anesthesia, pain management drug ➤ Five-year results with intracanalicular microstent ➤ Request for information about ocular imaging ➤ Post-hoc analysis of NMOSD treatment ➤ Investigational visual prosthesis implanted in blind patient ➤ ASCRS news and events
➤ Nerve growth factor being studied as a possible treatment for Sjogren’s-related dry eye ➤ Investigational RNA therapy doesn’t meet primary endpoint ➤ Phase 1 clinical trial for bioerodible, sustained anti-VEGF delivery ➤ Positive interim data for diabetic retinopathy treatment ➤ Positive results in trial for high-dose aflibercept ➤ Additional Phase 3 trial data for Beovu in DME ➤ ASCRS news and events
ASCRS Grand Rounds, a CME opportunity for ASCRS members, is hosted in partnership with major academic institutions, featuring two challenging cases with panel discussions. Here’s a recap of cases featured in the October–December 2021 editions of the series. Be sure to watch the full program to hear each panel’s thoughts and how the cases were ultimately handled.
➤ FDA approves generic Restasis ➤ Phase 3 trial for novel, preservative-free drug delivery platform ➤ Enrollment complete for Phase 3 blepharitis trial ➤ Enrollment complete for Phase 3 mydriasis reversal study ➤ Path forward for resubmission of drug-device combination product ➤ ‘Immunity and Inflammation in the Anterior Segment of the Eye’ report ➤ ASCRS news and events
➤ FDA approves first bispecific antibody for the eye ➤ FDA approves treatment for rare uveal melanoma ➤ New data on clinical programs investigating phentolamine ophthalmic solution ➤ Phase 2 clinical trial results published for investigational drug targeting allergic conjunctivitis ➤ Patient dosing begins for gene therapy to treat X-linked retinitis pigmentosa ➤ New effort to research glaucoma ➤ ASCRS news and events
➤ Study evaluates the potential for AI in cataract surgery ➤ Pre-clinical model for dry AMD ➤ Research finds up to 30% of wet AMD patients could stop injections ➤ Prospective study of a new home-based OCT device begins ➤ ASCRS news and events
If you want to take an organized tour while in the city, check out EyeWorld’s curated list.